LAMPRENE®


Capsules
scheduling status
S4
registration number
B/20.2.4/108, 53/20.2.4/0472
What LAMPRENE® contains
Clofazimine 100 mg Clofazimine 50 mg.
other ingredients
Capsule content: Butylated hydroxytoluene; Citric acid (anhydrous); Propylene glycol; Rapeseed oil (refined); Lecithin (E322); Beeswax (yellow); Soybean oil (hydrogenated); Soya-bean oils (partially hydrogenated). Capsule shell: Ethyl parahydroxybenzoate sodium; Propyl parahydroxybenzoate sodium; Ethylvanillin; Gelatin; Glycerol 85 % ; Black iron oxide (E172); Red iron oxide (E172); P-methoxy acetophenone.
Therapeutic classification
J04BA01.
© 2026 SAHPRA. ALL RIGHTS RESERVED